Tovey, H., Bliss, J., Tutt, A., Morden, J., Jarman, K., Martin, S., . . . Kilburn, L. (2015). Managing non-proportionality of hazards (PH) within TNT: A randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC). Trials.

Tovey, Holly, Judith Bliss, Andrew Tutt, James Morden, Katy Jarman, Sue Martin, Sarah Kernaghan, Christy Toms, a Lucy Kilburn. "Managing Non-proportionality of Hazards (PH) Within TNT: A Randomised Phase III Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic or Recurrent Locally Advanced Triple Negative (TN) or Brca1/2 Breast Cancer (BC)." Trials 2015.

Tovey, Holly, et al. "Managing Non-proportionality of Hazards (PH) Within TNT: A Randomised Phase III Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic or Recurrent Locally Advanced Triple Negative (TN) or Brca1/2 Breast Cancer (BC)." Trials 2015.